Compare Medpace Holdings Inc (MEDP) vs ProShares Ultra QQQ ETF (QLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs ProShares Ultra QQQ ETF — how do they compare? Medpace Holdings Inc trades at $534.03 (market cap $15.08B), while ProShares Ultra QQQ ETF trades at $89.42. Which is the better fit depends on your goals.
| MEDP | QLD | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $620.59 | $100.53 |
52-Week Low | $308.88 | $57.16 |
Enterprise Value | $14.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
QLD, the ProShares Ultra QQQ ETF, trades at $86.06, up 0.17% on the day. The technical outlook is bearish, with moving averages signaling a downtrend and key support at $85. Recent articles highlight its long-term performance, with over 10,000% total return since inception, but caution its leveraged structure amplifies risks, evidenced by a historical maximum drawdown exceeding 63%.
The outlook for QLD is heavily tied to the performance of the Nasdaq-100 index. While leveraged exposure offers potential for amplified gains during tech rallies, the daily reset mechanism poses significant volatility and decay risks in choppy markets. Investor focus remains on upcoming tech earnings and broader market trends for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About ProShares Ultra QQQ ETF
QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on QLD →
